The present state of the treatment of psoriasis at our clinic was reviewed, mainly in relation to cyclosporine (Neoral
®) therapy. Cyclosporine (Neoral
®) is confirmed to be effective in treating psoriasis, and it is, therefore, used by many medical institutions. Because cyclosporine (Neoral
®) therapy sometimes involves great cost, the optimal dosage regimen should be selected through good communication between the doctor and the patient, according to the severity of the patient's condition, age, duration of disease, occupation, and socioeconomic background. Therefore, it is desirable that cyclosporine (Neoral
®) is administered using a dosage regimen capable of reducing the economic burden on each patient while maintaining its therapeutic effectiveness, such as low-dose oral therapy and administration on alternate days.
View full abstract